Related references
Note: Only part of the references are listed.Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI The A4 Study
Ellen Grober et al.
NEUROLOGY (2022)
Prognostic Value of Learning and Retention Measures from the Free and Cued Selective Reminding Test to Identify Incident Mild Cognitive Impairment
Ellen Grober et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2022)
Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials
Thibault Mura et al.
ALZHEIMERS & DEMENTIA (2022)
Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults A Machine Learning Approach Using A4 Data
Kellen K. Petersen et al.
NEUROLOGY (2022)
Application of predictive models in boosting power of Alzheimer's disease clinical trials: A post hoc analysis of phase 3 solanezumab trials
Ali Ezzati et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2022)
Correspondence of CSF biomarkers measured by Lumipulse assays with amyloid PET
Katherine E. Volluz et al.
Alzheimers & Dementia (2021)
Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system
Ellen Grober et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)
Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease-related declines
Kelsey R. Thomas et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)
Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individuals
Xue-Ning Shen et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)
The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults
Philip S. Insel et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial)
Paul S. Aisen et al.
Alzheimers & Dementia (2020)
Timing of onset and rate of decline in learning and retention in the pre-dementia phase of Alzheimer's disease
Ellen Grober et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2019)
Current state of Alzheimer's fluid biomarkers
Jose Luis Molinuevo et al.
ACTA NEUROPATHOLOGICA (2018)
The free and cued selective reminding test for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: A prospective longitudinal study
Raquel Lemos et al.
JOURNAL OF NEUROPSYCHOLOGY (2017)
Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease
Suzanne E. Schindler et al.
NEUROBIOLOGY OF AGING (2017)
Cued memory decline in biomarker-defined preclinical Alzheimer disease
Kathryn V. Papp et al.
NEUROLOGY (2017)
Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis
S. Duke Han et al.
NEUROPSYCHOLOGY REVIEW (2017)
Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β
Elizabeth C. Mormino et al.
ALZHEIMERS & DEMENTIA (2017)
Free and Cued Selective Reminding Test - accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: A large-scale biomarker-characterized monocenter cohort study (ClinAD)
Marc Teichmann et al.
ALZHEIMERS & DEMENTIA (2017)
Certified normal: Alzheimer's disease biomarkers and normative estimates of cognitive functioning
Jason Hassenstab et al.
NEUROBIOLOGY OF AGING (2016)
Prediction of Alzheimer's Disease Dementia: Data from the GuidAge Prevention Trial
Francesca Di Stefano et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease
Emily C. Edmonds et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Neuropsychological Criteria for Mild Cognitive Impairment Improves Diagnostic Precision, Biomarker Associations, and Progression Rates
Mark W. Bondi et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
The A4 Study: Stopping AD Before Symptoms Begin?
Reisa A. Sperling et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
Erik von Elm et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
Secondary Prevention Trials in Alzheimer Disease The Challenge of Identifying a Meaningful End Point
Richard J. Kryscio
JAMA NEUROLOGY (2014)
The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline
Michael C. Donohue et al.
JAMA NEUROLOGY (2014)
Synergistic Effect of β-Amyloid and Neurodegeneration on Cognitive Decline in Clinically Normal Individuals
Elizabeth C. Mormino et al.
JAMA NEUROLOGY (2014)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
Catherine M. Roe et al.
NEUROLOGY (2013)
Screening for predementia AD Time-dependent operating characteristics of episodic memory tests
Carol A. Derby et al.
NEUROLOGY (2013)
Age-specific and Sex-specific Prevalence and Incidence of Mild Cognitive Impairment, Dementia, and Alzheimer Dementia in Blacks and Whites A Report From the Einstein Aging Study
Mindy J. Katz et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2012)
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimers disease
Carlos Cruchaga et al.
HUMAN MOLECULAR GENETICS (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Free and Cued Selective Reminding Identifies Very Mild Dementia in Primary Care
Ellen Grober et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2010)
Validity of the Free and Cued Selective Reminding Test in predicting dementia The 3C Study
S. Auriacombe et al.
NEUROLOGY (2010)
Spanish Multicenter Normative Studies (NEURONORMA Project): Norms for the Rey-Osterrieth Complex Figure (Copy and Memory), and Free and Cued Selective Reminding Test
Jordi Pena-Casanova et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2009)
Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease
Ellen Grober et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2008)
Memory impairment on free and cued selective reminding predicts dementia
E Grober et al.
NEUROLOGY (2000)
Share Paper
